Use of Interim PET Scan to Modify Therapy in Advanced Hodgkin's Lymphoma in Order to Improve Outcomes
NCT01304849
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
50
Enrollment
OTHER
Sponsor class
Conditions
Hodgkin's Lymphoma
Interventions
DRUG:
Escalated BEACOPP
Sponsor
Cancer Institute WIA